Jaundice Clinical Manifestation

Jaundice clinical manifestation describes yellowish skin discolouration from bilirubin accumulation. Unconjugated hyperbilirubinaemia from haemolysis or impaired conjugation produces early jaundice. Conjugated hyperbilirubinaemia from hepatic excretion defects produces late jaundice. Drug-induced hepatotoxicity frequently presents as jaundice. Severity assessment guides treatment urgency.

Bilirubin fractionation distinguishes hyperbilirubinaemia types. Liver function testing identifies hepatic dysfunction. Regulatory monitoring detects drug-induced jaundice. Dose interruption or discontinuation may reverse jaundice. Post-approval surveillance identifies jaundice patterns.